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Abstract
Background: Long-term multicentre studies are subject to numerous factors that may affect the integrity of their
conclusions. Quality control and standardization of data collection are crucial to minimise the biases induced by
these factors. Nevertheless, tools implemented to manage biases are rarely described in publications about
population-based cohorts. This report aims to describe the processes implemented to control biases in the
Constances cohort taking lung function results as an example.
Methods: Constances is a general-purpose population-based cohort of 200,000 participants. Volunteers attend
physical examinations at baseline and then every 5 years at selected study sites. Medical device specifications and
measurement methods have to comply with Standard Operating Procedures developed by experts. Protocol
deviations are assessed by on-site inspections and database controls. In February 2016, more than 94,000
participants yielding around 30 million readings from physical exams, had been covered by our quality program.
Results: Participating centres accepted to revise their practices in accordance with the study research specifications.
Distributors of medical devices were asked to comply with international guidelines and Constances requirements.
Close monitoring enhanced the quality of measurements and recordings of the physical exams. Regarding lung
function testing, spirometry acceptability rates per operator doubled in some sites within a few months and global
repeatability reached 96.7 % for 29,772 acceptable maneuvers.
Conclusions: Despite Constances volunteers being followed in multiple sites with heterogeneous materials, the
investment of significant resources to set up and maintain a continuous quality management process has proved
effective in preventing drifts and improving accuracy of collected data.
Keywords: Cohort study, Epidemiological methods, Measurement tool development, Methodology, Respiratory
Background
Developing large-scale prospective cohorts is of utmost
importance to address epidemiological, clinical or patho-
physiological research questions. In such cohorts, quality
control is a major issue to ensure that collected data are
sufficiently reliable and robust.
Constances is a large population-based general-purpose
cohort intended to serve as an open epidemiologic
research infrastructure accessible to the research
community and to provide public health information [1].
At term, it will comprise a sample of 200,000 participants
aged 18–69 years at inclusion who are representative of
the French adult population. The survey was launched
towards the end of 2012 and has already included more
than 94,000 volunteers (February 2016). New participants
are continuously being included and the cohort will be
fully constituted by the end of 2018.
At inclusion, volunteers are asked to complete a
questionnaire and attend a medical exam in one of the 20
participating recruitment sites located throughout France.
These sites are Health Screening Centres (HSC) managed
by the national social security fund (CNAMTS) to provide
free health check-ups for the French population [2]. As
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well as the medical examination, laboratory tests and
questionnaires, data related to the participants are
extracted from national health and social databases on a
regular basis. The volunteers are followed up by annual
questionnaires and invited to attend a new medical exam
at a participating site every 5 years (Fig. 1).
During the physical exam, biometry (weight, height,
waist and hip circumference), blood pressure, electrocar-
diogram, vision, hearing and lung function are measured.
Blood and urine samples are collected for laboratory tests.
Cognitive and physical functioning assessments are
conducted for volunteers 45 years and older.
All the data collected in the HSCs as well as from the
other data sources (questionnaires, administrative data-
bases) are transferred to the central Constances site where
the data are consolidated in a single centralized database.
Numerous procedures and controls have been set up for
the Constances study in order to ensure that the data is of
high quality and reproducible and to allow appropriate
assessment of potential measurement biases. The present
paper focuses on quality issues encountered in the cohort,
describes how these issues were addressed and the results
of corrective measures with special interest in spirometry
as an illustrative example. For clinical chemistry, several
publications demonstrate the importance of close
monitoring to correctly assess these biases. A recent
example from Withehall II emphasized this necessity for
cognitive testing [3]; non-adherence to the protocol was
not identified at the time of the data collection leading to
complex identification of outliers.
However, it would have been very ambitious to cover
all parts of the protocol in a single article. We therefore
intend to discuss the biological and cognitive parts in
separate papers. We describe here the quality assurance
and controls implemented for the medical examination
part of the protocol.
Methods
Quality assurance
Standard operating procedures
One goal of the study protocol and Standard Operating
Procedures (SOPs, which define the medical device
specifications and detail the measurement methods for
each type of data) was to standardize methods to ensure
successful replication of data collection for all volunteers
irrespective of when, where and by whom they are per-
formed [4, 5].
For that purpose, we organized working groups super-
vised by experts from each domain and composed of
personnel from the participating sites (MDs and nurses),
Fig. 1 Study progression
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experts of the corresponding field, epidemiologists and
quality assurance specialists.
The SOPs describe the materiel admissible for the study,
the required annual certification, and the periodic checks
or maintenance. All the steps of each measurement are
detailed to minimize inter-operator variability [5] Table 1.
Material
The medical devices with their specific software and the
middleware are purchased by the HSCs at a local level.
Consequently, not all the participating sites have the
same equipment. As precision and accuracy could differ
depending on the material used, the manufacturer’s
instructions for each device used for the measurements
were initially reviewed [6] and are updated throughout
the study to take into account any changes in material
or versions of middleware.
If the technology of a device undergoes significant
modifications, the measurements for a series of volun-
teers are doubled within a short period (first with the
new device and second with the previous one).
Quality controls performed during the pilot study re-
vealed that various middleware used by the study nurses
did not transfer the exact value of the medical device
measurements to the local database. These discrepancies
were reported to the corresponding study site or to the
medical device distributor and they were encouraged to
quickly update their software. The correct values were
added to the study Case Report Form (CRF) manually.
Pre-study site qualification
Prior to inclusion, we performed an on-site inspection of
each HSC and presented the study to the staff. During
this visit, we checked the staff ’s qualifications, the study-
related equipment in the patient examination rooms and
the source documentation. We also obtained the investi-
gators’ agreements to allow the site monitors direct ac-
cess to the relevant data sources.
Training
All study site personnel involved in the study had to be
trained by a study monitor or an experienced member of
the site staff prior to participation. Training certificates
were delivered by the monitor, stored on site, and
registered in a monitoring database. A study monitor
was also present on site for the first 2 days of inclusion
to support the study staff.
Monitoring of measurements
To minimize drifts over time [7], the practices of all the
study-site staff are monitored on a monthly basis. All
steps of each SOP are recorded on a detailed checklist
and the monitor ensures that the observed practices are
compliant with the protocol and SOPs. Deviations are
documented in a visit report and the related standards
are reviewed with the study site member.
Case report form and data transfer
All the medical records of the participating sites are
electronic and data are stored in a local database, the
structure of which is common to all sites. Most of the
data collected during the physical examinations are then
extracted from the local database and exported to the
Constances data centre with cryptography procedures.
This is to ensure standardization of a part of the data
collection and to reduce potential data capture errors by
the study nurse who enters source document informa-
tion in the study CRF [8].
For research purposes, the experts requested to increase
the precision of some data and to collect some additional
specific items. To satisfy their expectations a CRF was
specifically designed to complete the data collection.
Quality control process
Validation plan
Two validation plans run permanently in the database.
The first consists in a crosscheck of identical data
collected from different sources, the data entered in the
CRF being compared with the data extracted from the
electronic medical records of the sites to check for
consistency. This is feasible when the study procedures
are requesting, for a specific item, a higher precision
than the value usually entered in the medical records of
the sites. The second validation plan tracks missing data,
discrepancies between different questionnaires, out of
range values or any warning requiring consistency check
as predefined by the researchers.
Data flagged by the validation plans generate queries
processed directly by the data managers or forwarded to
the monitors to be answered during the on-site moni-
toring visits.
On-site verification
Each month samples of the data exported from the site
and imported in the Constances database are extracted
from the database for quality controls. First, for each
category of data the monitor identifies the source docu-
ment (where the data was initially recorded). For data
entered directly in the local electronic medical record,
the site prints out the results. The study monitor then
checks the consistency between the site data and the
Constances database extraction.
For any discrepant data, the study monitor identifies the
origin of the discrepancy. In the case of data entry error,
the correction is transmitted to the Constances data centre.
If the discrepancy does not originate from the data entry
process, then one of the electronic data transfers may be
involved (medical device to middleware, middleware to
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Table 1 Required equipment and maintenance rules
Exam Equipment recommendations Daily verification Monthly verification Annual verification Procedure
Weight • Class III medical scale CE marked
• Required precision: ± 0.1 kg
• Amplitude: 2.0–150.0 kg minimum
• Spirit level verification
• Zero displayed
before use
NA • Performed by an external
certified body.
• Volunteer in underwear, motionless.
• Measurement read by the nurse once
stabilization obtained.
Height • Measuring rod
• Graduation: 1 cm
• Amplitude: 60–200 cm
• 10 cm space between heels
indicated by floor markings.
• 0 graduation at the
ground level – 1 mm
tolerance permitted
• Cross-checking
with the tape
measure
• Performed by an external
certified body.
• Volunteer standing, arms at sides, inside
heels 10 cm apart, head upright, looking
straight, deep breath in. Measurement
read by the nurse, with slider at eye-level.
Waist-hips-abdominal
circumference
• Tape measure with 2 sides of
different colors.
• Graduation: 1 cm
• Amplitude: 0–150 cm
• Signs of wear • Cross-checking
with the
measuring rod
• Renew every year • Volunteer in underwear, standing with
feet shoulder-width apart, arms slightly
apart, motionless.
• Palpation of anatomical landmarks for
right positioning (Waist: mid-axillary line;
Hips: widest level over the greater trochanters)
• Ensure horizontality of the tape measure with
no twists.
• Tape measure snug but not digging into the skin.
• Measurement read by the nurse on the exhale.
Arterial pressure • Tensiometers provided by The
“Constances” research team: OMRON 705.
• Accuracy of measurement: ±3 mmHg
• Amplitude: 0–300 mmHg
• Search for anomalies
of the entire pneumatic
circuit
NA • Centralized and organized
by the Constances
research team
• Point of reference on the blood pressure cuff
according to the arm circumference.
• Volunteer in supine position.
• First reading after a 5-minute rest, second
reading on the contralateral arm, third reading
after a 1-minute pause on the arm with the highest
systolic blood pressure.
• Orthostatic hypotension measured after
standing for 1 min
ECG • 12 standard ECG leads
• Screen display and software program
that ensures the overall management
• Recording features: speed (25 mm per second),
amplitude (10 mm by mV), leads and filters.
• Examination table with a minimum width
of 65 cm to avoid muscular contractions or
arms falling off table.
• Signs of wear.
• Calibration signal at
the beginning of
each trace.
NA • Performed by an
external certified body.
• Volunteer in supine position, calm, arms at sides.
• Thorough skin preparation (remove grease)
• Ensure a good electrode-to-patient contact.
• Palpation of anatomical landmarks for
proper placement of the electrodes
Far visual acuity • Monoyer scale
• Floor marking to indicate the required
reading distance of 3 or 5 m
• Unit: 1/10
• Required precision: ± 1/10
• Amplitude: 0/10–10/10
• Signs of wear, dirt • Signs of wear NA • Volunteer standing or seated
• For monocular visual acuity: cover
placed on one eye with no pressure
Near visual acuity • Parinaud scale
• Unit: Parinaud
• Amplitude: 1.5–20
• Specific device provided by Constances to
standardize the scale-brow distance (33 cm).
• Signs of wear, dirt • Signs of wear NA • Volunteer seated
• Specific device in contact with the
volunteer’s brow
• For monocular visual acuity:
cover placed on one eye with no pressure
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Table 1 Required equipment and maintenance rules (Continued)
Audition • Required precision: ± 3 dB from 500 to
4,000Hz and ± 5 dB beyond
• Amplitude: −10 to 85 dB by 5 dB
steps minimum
• Test hearing by air conduction using a
pulsed tone at various frequencies
(from −10 to 85 dB – change by 5 dB steps).
• Control test of each
frequency at 60 dB
both sides
NA • Performed by an external
certified body
• Response mode: hand raised / response button
pressed, held as long as tone is heard
• Volunteer unable to see the operator
• Headphones placed by the operator
• Start by a demonstration
• Otoscopy (to detect excessive earwax)
Spirometry • As per requested by ATS/ERS task force
• Unit: L
• Required precision: 0.035 L
• Amplitude: 0–8 L
• Performed in accordance
with the ATS/ERS guidelines
NA • Performed by an
external certified
body in accordance
with the ATS/ERS guidelines
• Performed in accordance with the
ATS/ERS guidelines
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electronic medical records, or electronic medical records to
the Constances datacentre). In this case, the monitor must
identify the systematic error and all related data have to be
corrected and reintegrated into the Constances database.
Permanent monitoring of the inter-operator and inter-site
variability
Inter-operator variability is an important indicator of
quality [9]. It is also an important tool for monitoring
practices, identifying drifts and generating targeted re-
minders and training. Although biometric measurements
are routinely tested, we also decided to follow-up other
variables as indicators of SOP compliance. Examples are
shown in Table 2.
Results
An example of the quality assurance and control in
Constances: lung function testing
With more than 94,000 participants included by Febru-
ary 2016, around 30 million readings from physical
exams have been covered by our quality policy system.
To discuss the issues and the first results, we decided to
take the example of spirometry, one of the eight mea-
surements performed.
The whole process of lung function testing is detailed
in depth in the ATS/ERS guidelines [10]. The study
monitor checks that the study-nurse adheres to all the
requirements during the on-site visits. Within- and
between-maneuver quality criteria are checked on site by
the monitor and reproducibility is systematically assessed
for all subjects as part of the validation plan program.
While most of the requirements are objective and can
thus be checked without a shadow of doubt, one of the
ARS/ERS guidelines criterion is more subjective: categoriz-
ing the maneuver as acceptable after inspection of the flow-
volume curve. As this involves some interpretation, the
Respiratory Experts Review Board organizes an annual cen-
tral review to assess the curves considered as acceptable
from 1 % of the curves randomly sampled each month.
Material and distributors
During the pre-study site qualification phase, we studied
the device documentation collected from each site
(technical notice, operating manual and commercial
leaflet) to identify differences between the operator
practices and our SOP.
Although all the manufacturers equipping the
Constances sites produced documentation stating that
their devices satisfy the ATS/ERS recommendations,
some concerns arose from analyzing practices and the
device results sheets.
As some of the instructions provided by the distributors
were actually not in accordance with ATS/ERS recom-
mendations, we experienced difficulties explaining to the
study nurses that they would have to modify their practice.
The strongest resistance we met was to re-introduce daily
quality control in sites equipped with ultrasound spirome-
ters. The distributor’s documentation states that the
ultrasound spirometers require neither calibration nor
calibration checks. Calibration establishes the relationship
between sensor-determined values of flow or volume and
the actual flow or volume, whereas calibration checks
validate that the device is within calibration limits [10].
With pneumotachographs (the spirometers used by the
sites before acquiring an ultrasound device), calibration
and calibration checks were closely linked.
Distributors promote ultrasound spirometers by
highlighting that they no longer require any form of
calibration and even suggest that the calibration syringe
would become redundant. Once equipped with ultra-
sound spirometers, the sites followed this advice and
stopped performing the calibration procedures. When
we reminded the sites that ATS/ERS guidelines state that
it is mandatory to perform daily verification, the
distributor used a published study to assert that verifica-
tion was not necessary [11]. The abstract of this study,
claiming a volume accuracy higher than 3 % for at least
4 years, encouraged the users of the referenced ultra-
sound spirometer to abandon daily calibration checks.
To convince the sites to restore daily calibration
checks, we used arguments extracted from the same
Table 2 Indicators of SOP compliance
Measurement Indicator Error
Weight Distribution of decimal Results rounded
by operator
Waist (Waist/Abdominal) ratio Palpation of anatomical
landmarks not
systematically performed
by operator
Arterial
pressure
Distribution of the
left/right side for the
3rd reading
Two first readings
performed on the
same arm
Arterial
pressure
Higher blood pressure Chronograph
not respected
Near visual
activity
Lower Parinaud Specific device to respect
distance not used
Far visual
activity
Higher scores in 1/10 Distance not respected
Audition High distribution of last
digit results equal to 0
Test performed with steps
of 10db instead of 5 dB
Audition Lower percentage of
patient with negative
scores
Test performed without
testing negative values.
Spirometry Lower percentage of
acceptable maneuver
declared
Insufficient patient
coaching or training
of the study-nurse
Spirometry (repeatability declared/
repeatability calculated)
ratio
Insufficient training
of the study nurse
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publication in its entirety. Indeed, the authors explained
in the methods section that, as recalibration of the
device was not possible, users repeated verification until
success. Failures were not logged and analysis was
limited to the range of the successful verifications. The
authors minimized this bias and explained in the limitations
section that the initial failures were almost always due to
human error. The authors revealed an additional important
fact: two of the 34 spirometers had been returned to the
manufacturer after repeated verification failures.
After having considered these study results, the sites
became sensitive to the importance of daily verification,
understanding that these devices could also malfunction
and that the best way of preventing the generation of
corrupted data remained daily verifications.
In some sites using pneumotachographs, we also iden-
tified unacceptable communication from some distribu-
tors. When some sites experienced difficulties calibrating
the spirometer, one distributor offered to redefine some
parameters, which consisted in actually changing the ac-
ceptable error from 3 to 10 %. The sites refused to have
the parameters modified and did not perform the exam
until the manufacturer had replaced the devices.
Other issues were also identified. For example, the
results sheets for some spirometers mentioned “ERS
1993” [12]. The distributor confirmed that the criteria
had not been updated in order to obtain more repeatable
maneuvers (difference of <0.2 l versus <0.15 l according
to the 2005 criteria).
With most brands, we also identified errors in the de-
cision tree programs for Forced Vital Capacity (FVC)
and Forced Expiratory Volume in 1 s (FEV1) recordings.
We noticed that after having obtained three acceptable
and two repeatable maneuvers, FVC and FEV1 could be
extracted from the same maneuver whereas the largest
FVC and the largest FEV1 did not belong to the same
curve. As ATS/ERS guidelines recommend that “the
largest FVC and the largest FEV1 (BTPS) should be
recorded […] even if they do not come from the same
curve”, we reported this issue to the distributors or man-
ufacturers. As they were not reactive, we had to change
the Case Report Form to collect FVC and FEV1 of the
three usable curves.
Operator follow-up and training
Even though operators had been performing spirometry
in their daily practice for years, training was provided by
the study monitor during the “site initiation visit”.
Monthly on-site verification by study monitors found
that some parts of the SOP were not implemented, such
as hourly temperature control or demonstration of the
technique to the patient. Once the study monitor had
identified a deviation, he/she systematically retrained the
operator. However, the presence of a study monitor in
the examination room inevitably makes the operator
more vigilant about potential protocol deviations. To
prevent this evaluation bias, we analyzed the rate of
acceptable maneuvers declared per site and per operator
for the first 6329 spirograms collected. We noted con-
siderable differences between sites: while the overall
average percentage of acceptable maneuvers was 69 %
(4369 of 6329), they ranged from 35.2 % (135 of 384) to
91.5 % (108 of 118).
The site with the lowest performance had conducted
384 spirograms, involving 13 different operators who
had conducted more than ten exams for the study; the
percentage of acceptable spirograms per operator varied
from 11 to 65 %. However, as non-acceptable maneuvers
were not sent to the Constances data centre, the weak-
ness of some operators did not impact the global quality
of FVC and FEV1 values collected.
The repeatability of the acceptable maneuvers (accord-
ing to the 2005 criteria) is also an important indicator of
quality. This indicator was high-grade: 93.4 % of the
acceptable maneuvers were declared repeatable (4081 of
4369) ranging from 82.1 to 100 % according to the site.
The repeatability of each maneuver was checked by
calculation: although no more than 1.1 % (45 of 4081)
were wrongly declared as repeatable, 277 were incor-
rectly declared as non-repeatable, giving a total of
97.5 % (4260 of 4369) repeatable spirograms. These
global rates were consistent with the best data reported
in the international literature [13, 14].
We thus concluded that the factor that we had to
improve was the acceptability rates for some operators.
Thus, the sites were sent the acceptability and repeat-
ability rates per operator and per site compared to the
other sites. We subsequently contacted the sites to
discuss these figures. Most were very reactive and orga-
nized additional training. By the end of 2013, all the sites
had increased their acceptability and repeatability rates.
The percentage of acceptable and repeatable maneuvers
(calculated for all maneuvers performed) ranged from
44.9 % (758 of 1690) to 95.0 % (700 of 737). Figure 2
presents the inter-site variability of these rates.
Some sites requested individual status reports to
follow the progression of each operator, and we noticed
that the percentage of acceptable spirograms increased
for each of them. Figure 3 illustrates the quality
improvement of repeatability per operator in the weakest
site 1 year after corrective actions had been introduced.
Central review verification
In August 2014, the Respiratory Experts Review Board
received a random sample of maneuvers (20 per site)
qualified by the sites as acceptable and repeatable. A
total of 335 maneuvers were subsequently examined by
the Board.
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Fig. 2 Graph: “Repeatable maneuvers per site end 2013”. X-axis: “% of repeatable maneuvers”. Y-axis: “Site”. “Repeatability calculated from results
of 25 848 maneuvers”. Blue “Repeatable”. Red “Non repeatable”
Fig. 3 Graph: “CES 13: Repeatable maneuvers per operator”. X-axis: “% of repeatable maneuvers”. Y-axis: “Operator”. “Repeatability calculated for
operators having performed >100 maneuvers during the first period”. Blue: “2012–2013 (1 097 maneuvers performed)”. Red: “2014
(793 maneuvers performed)
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They considered that 99.4 % of the maneuvers were
free from artefacts and that 98.2 % had a good start.
Unexpectedly, they noticed that the exhalation duration
was not provided in the results report in most cases
(85.9 %) but that volume-time curves showed an accept-
able plateau. Hence the Board decided to ask the study
monitors to measure the exhalation duration of maneu-
vers in one or two volunteers during each of their
monthly on-site visits so as to record this value for
approximately 1 % of the participants.
For between-maneuver criteria, the Respiratory Experts
Review Board was not able to evaluate the repeatability cri-
teria for 26.6 % of the maneuvers as only the greatest FVC
and FEV1 values of the same curve (considered by the spir-
ometer software as the best one) were printed out. They
reported that 94.6 % of the 239 remaining maneuvers were
repeatable, which is consistent with our analysis of a larger
sample (Table 3). We could verify that 96.7 % of the
maneuvers satisfied the between-maneuver criteria.
Discussion
The collection of high quality data for 200,000 partici-
pants attending a physical examination, and undergoing
laboratory tests and cognitive and functional tests relies
on active participation of all participating centres. As
described for lung function testing, the study-site
personnel accepted to adapt their practices to the study
research specifications for all exams in the interests of
standardizing the measurements and the study report
documentation. In parallel, the medical device distribu-
tors were challenged to satisfy Constances requirements.
Albeit not perfect, the Constances the quality assurance
and control program showed to be efficient.
Conclusions
The study team invests considerable human and finan-
cial resources to implement and maintain a high quality
management process to produce data by rigorous con-
trol of materials and methods. Similar improvements as
those described for the spirometry have also been
observed for the other physical examinations. All in all,
researchers will be able to use the data generated from
Constances confident in the knowledge that the data
were collected via robust processes.
Abbreviations
ATS, American Thoracic Society; BTPS, body temperature and pressure,
saturated; CNAMTS, Caisse nationale d’assurance maladie des travailleurs
salariés; CRF, case report form; ERS, European Respiratory Society; FEV1,
forced expiratory volume in 1 s; FVC, forced vital capacity; NA,
not applicable; SOP, standard operating procedures
Acknowledgments
The authors wish to thank the INSERM-Versailles Saint Quentin en
Yvelines University “Population-based Epidemiological Cohorts Unit”
(Cohortes épidémiologiques en population) which designed and manages the
Constances Cohort Study. They also thank the National Health Insurance Fund
(“Caisse nationale d’assurance maladie des travailleurs salaries”, CNAMTS) and its
Health Screening Centres (“Centres d’examens de santé”), responsible for
collecting a large part of the data, as well as the National Retirement
Fund (Caisse nationale d’assurance vieillesse), ClinSearch, Asqualab and
Eurocell, responsible for the data quality control.
Funding
The Constances Cohort Study was funded by the National Health Insurance
Fund (Caisse nationale d’assurance maladie des travailleurs salaries, CNAMTS),
the Ministry of Health, the Council of the Ile de France Region, and by the
Cohorts TGIR IReSP-ISP INSERM (Ministère de la santé et des sports, Ministère
délégué à la recherche, Institut national de la santé et de la recherche
médicale, Institut national du cancer et Caisse nationale de solidarité pour
l’autonomie). The Constances Cohort Study is an « Infrastructure Nationale en
Biologie et Santé » and benefits from a grant from ANR (ANR-11-INBS-0002).
Availability of data and materials
The data supporting the findings stem from the CONSTANCES database.
For further information and details please contact marie.zins@inserm.fr.
Authors’ contributions
MZ and MG designed and managed the Constances cohort, they initiated
the article and are guarantors. FR drafted the paper and supervised the
monitoring of Constances. SL, AO, and EB implemented the trial and
managed the recruitment in collaboration with the Health Screening
Centres. AB managed a Health Screening Centre and collaborated closely
with the Constances team to draft the SOPs. NR, VG, and TP participated as
members of the Respiratory Experts Review Board. All authors read and
approved the final manuscript.
Competing interest
The authors declare that they have no competing interest.
Consent for publication
Informed consent was obtained from all participants included in the study.
Ethics approval and consent to participate
According to the French regulations, the CONSTANCES Cohort project has
obtained the authorization of the National Data Protection Authority
(Commission nationale de l’informatique et des libertés—CNIL). CONSTANCES
was approved by the National Council for Statistical Information (Conseil
national de l’information statistique—CNIS), the National Medical Council
(Conseil national de l’Ordre des médecins—CNOM), the Central Institutional
Review Board of the National Institute for Medical Research-INSERM.
Author details
1CLINSEARCH, 110 Avenue Pierre Brossolette, 92240 Malakoff, France. 2UMS
011 Inserm - UVSQ « Cohortes épidémiologiques en population », 16 avenue
Paul Vaillant Couturier, 94 807 Villejuif, France. 3Centre d’examens de santé
d’Angoulême, 5 rue la Croix Lanauve, 16024 Angoulême, France. 4AP-HP,
Service de Pneumologie et d’Oncologie Thoracique, Hôpital Ambroise-Paré,
Boulogne, France. 5Service de Pneumologie et Service EFR, Hôpital Calmette,
CHU Lille, F-59000 Lille, France. 6EA2511, Université Paris Descartes et Service
de Pneumologie, Hôpital Cochin, 27 rue du Fg Saint Jacques, 75014 Paris,
France.
Table 3 Acceptable maneuvers reported by the sites (N = 29,799)
Repeatability criteria satisfied
Study nurse assessment
reported in the CRF
Calculated with
FVC,FEV1 data
entered in the CRF
Frequency Percentage
Repeatable Repeatable 28,396 95.36
Not repeatable Repeatable 253 0.85
Assessment missing Repeatable 151 0.51
Repeatable Not repeatable 804 2.70
Not repeatable Not repeatable 168 0.56
Assessment missing Not repeatable 7 0.02
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